-+ 0.00%
-+ 0.00%
-+ 0.00%

CREATE MEDICINES: RECEIVES APPROVAL TO INITIATE FIRST-IN-HUMAN PHASE 1/2 CLINICAL TRIAL OF IN VIVO CAR-T CANDIDATE CRT-402 FOR AUTOIMMUNE DISEASES

Reuters·07/30/2026 11:15:19

Please log in to view news